These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 36388685)
1. Identification of a five m6A-relevant mRNAs signature and risk score for the prognostication of gastric cancer. Yin L; Feng S; Sun Y; Jiang Y; Tang C; Sun D J Gastrointest Oncol; 2022 Oct; 13(5):2234-2248. PubMed ID: 36388685 [TBL] [Abstract][Full Text] [Related]
2. N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patients. Xu S; Chen W; Wang Y; Zhang Y; Xia R; Shen J; Gong X; Liang Y; Xu J; Tang H; Zhao T; Zhang Y; Chen T; Wang C BMC Cancer; 2022 Jul; 22(1):721. PubMed ID: 35778697 [TBL] [Abstract][Full Text] [Related]
3. Hub Long Noncoding RNAs with m6A Modification for Signatures and Prognostic Values in Kidney Renal Clear Cell Carcinoma. Lin G; Wang H; Wu Y; Wang K; Li G Front Mol Biosci; 2021; 8():682471. PubMed ID: 34295922 [No Abstract] [Full Text] [Related]
4. Dysregulated N6-methyladenosine methylation writer METTL3 contributes to the proliferation and migration of gastric cancer. Liu T; Yang S; Sui J; Xu SY; Cheng YP; Shen B; Zhang Y; Zhang XM; Yin LH; Pu YP; Liang GY J Cell Physiol; 2020 Jan; 235(1):548-562. PubMed ID: 31232471 [TBL] [Abstract][Full Text] [Related]
5. Identification and Validation of an m6A Modification of JAK-STAT Signaling Pathway-Related Prognostic Prediction Model in Gastric Cancer. Jiang F; Chen X; Shen Y; Shen X Front Genet; 2022; 13():891744. PubMed ID: 35928449 [No Abstract] [Full Text] [Related]
6. Identification of three m6A-related mRNAs signature and risk score for the prognostication of hepatocellular carcinoma. Li Z; Li F; Peng Y; Fang J; Zhou J Cancer Med; 2020 Mar; 9(5):1877-1889. PubMed ID: 31943856 [TBL] [Abstract][Full Text] [Related]
7. Expression Status And Prognostic Value Of M6A-associated Genes in Gastric Cancer. Guan K; Liu X; Li J; Ding Y; Li J; Cui G; Cui X; Sun R J Cancer; 2020; 11(10):3027-3040. PubMed ID: 32226518 [No Abstract] [Full Text] [Related]
8. Identification of an EMT-Related Gene Signature for Predicting Overall Survival in Gastric Cancer. Dai W; Xiao Y; Tang W; Li J; Hong L; Zhang J; Pei M; Lin J; Liu S; Wu X; Xiang L; Wang J Front Genet; 2021; 12():661306. PubMed ID: 34249086 [TBL] [Abstract][Full Text] [Related]
9. The m6A methyltransferase METTL14 inhibits the proliferation, migration, and invasion of gastric cancer by regulating the PI3K/AKT/mTOR signaling pathway. Liu X; Xiao M; Zhang L; Li L; Zhu G; Shen E; Lv M; Lu X; Sun Z J Clin Lab Anal; 2021 Mar; 35(3):e23655. PubMed ID: 33314339 [TBL] [Abstract][Full Text] [Related]
10. Identification of a novel m6A-related lncRNA pair signature for predicting the prognosis of gastric cancer patients. Wang JM; Li X; Yang P; Geng WB; Wang XY BMC Gastroenterol; 2022 Feb; 22(1):76. PubMed ID: 35189810 [TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer. Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183 [TBL] [Abstract][Full Text] [Related]
12. Integrated risk scores from N6-methyladenosine-related lncRNAs are potential biomarkers for predicting the overall survival of bladder cancer patients. Huang X; Wang HF; Huang S Front Genet; 2022; 13():906880. PubMed ID: 36061188 [No Abstract] [Full Text] [Related]
13. Comprehensive analysis of the m6A-related molecular patterns and diagnostic biomarkers in osteoporosis. Bai Q; Shi M; Sun X; Lou Q; Peng H; Qu Z; Fan J; Dai L Front Endocrinol (Lausanne); 2022; 13():957742. PubMed ID: 36034449 [TBL] [Abstract][Full Text] [Related]
14. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer. Song Y; Qu H BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619 [TBL] [Abstract][Full Text] [Related]
15. m6A genotypes and prognostic signature for assessing the prognosis of patients with acute myeloid leukemia. Fu C; Kou R; Meng J; Jiang D; Zhong R; Dong M BMC Med Genomics; 2023 Aug; 16(1):191. PubMed ID: 37596597 [TBL] [Abstract][Full Text] [Related]
16. TEAD4 functions as a prognostic biomarker and triggers EMT via PI3K/AKT pathway in bladder cancer. Chi M; Liu J; Mei C; Shi Y; Liu N; Jiang X; Liu C; Xue N; Hong H; Xie J; Sun X; Yin B; Meng X; Wang B J Exp Clin Cancer Res; 2022 May; 41(1):175. PubMed ID: 35581606 [TBL] [Abstract][Full Text] [Related]
17. Construction and validation of a novel coagulation-related 7-gene prognostic signature for gastric cancer. Wang B; Zou D; Wang N; Wang H; Zhang T; Gao L; Ma C; Zheng P; Gu B; Li X; Wang Y; He P; Ma Y; Wang X; Chen H Front Genet; 2022; 13():957655. PubMed ID: 36105100 [No Abstract] [Full Text] [Related]
18. Risk Score Prediction Model of Prognosis in GC Patients by Age and Gender Combined With m6A Modification Genes FTO and RBM15. Yue L; Zhang R; Chen S; Duan G Front Cell Dev Biol; 2022; 10():710708. PubMed ID: 35433701 [No Abstract] [Full Text] [Related]
19. Prognostic signature composed of transcription factors accurately predicts the prognosis of gastric cancer patients. Zhou L; Chen Z; Wu Y; Lu H; Xin L Cancer Cell Int; 2021 Jul; 21(1):357. PubMed ID: 34233659 [TBL] [Abstract][Full Text] [Related]
20. Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma. Yu J; Mao W; Sun S; Hu Q; Wang C; Xu Z; Liu R; Chen S; Xu B; Chen M Front Oncol; 2021; 11():663263. PubMed ID: 34123820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]